- Future Students
- DVM degree program
- Graduate Programs
- Request information
- Contacts, Map, and Directions
- Current Students
- Faculty & Staff
Filters: Keyword is Female [Clear All Filters]
Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Aralar P, Wu M, Young LS. 2001. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.. Antimicrobial agents and chemotherapy. 45(1):217-22.
Bermudez LE, Petrofsky M, Stevens P. 1998. Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.. Immunology. 94(3):297-303.
Bermudez LE. 1986. The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report.. Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.]. 19(2):159-65.
Bermudez LE, Martinelli J, Petrofsky M, Kolonoski P, Young LS. 1994. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.. The Journal of infectious diseases. 169(3):575-80.
Bermudez LE, Kolonoski P, Seitz LE, Petrofsky M, Reynolds R, Wu M, Young LS. 2004. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.. Antimicrobial agents and chemotherapy. 48(9):3556-8.
Bermudez LE, Kolonoski P, Young LS, Inderlied CB. 1994. Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.. Antimicrobial agents and chemotherapy. 38(8):1844-8.
Bermudez LE, Inderlied CB, Kolonoski P, Wu M, Barbara-Burnham L, Young LS. 1996. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.. Antimicrobial agents and chemotherapy. 40(3):546-51.
Bermudez LE, Motamedi N, Chee C, Baimukanova G, Kolonoski P, Inderlied C, Aralar P, Wang G, Phan LT, Young LS. 2007. EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.. Antimicrobial agents and chemotherapy. 51(5):1666-70.